ArticleAntonie van Leeuwenhoek2025
Effects of cypermethrin insecticide on the growth and plant growth-promoting activity of Burkholderia-like strain (UAGC867) and Pseudomonas-affiliated strain (UAGC97).
Article in Antonie van Leeuwenhoek, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Brazil is a global leader in grain production, with corn reaching 122 million tons in the 2024/2025 harvest. Pest control, particularly of Spodoptera frugiperda, depends heavily on cypermethrin, a Class II hazardous synthetic insecticide with significant environmental risks. This study assessed the tolerance and degradation capacity of Pseudomonas-affiliated strain and Burkholderia-like strain in cypermethrin-contaminated environments, along with their indole-3-acetic acid (IAA) production and impact on early maize development. Both strains tolerated the insecticide and grew at varying concentrations, with Burkholderia-like strain showing superior degradation potential at 25 mg L⁻
Indexed as
Identifiers
41400743What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.